Komodo Health

Komodo Health is a technology platform company that aims to create a new standard for real-world data and analytics in healthcare. It pairs one of the industry's most comprehensive views of patient encounters, called the healthcare Map, with enterprise software and machine learning algorithms. The healthcare Map captures the medical, clinical, laboratory, and pharmaceutical encounters of over 330 million patients across the US healthcare system, including 15 million new clinical encounters daily.

Komodo Health uses advanced AI and machine learning to normalize, de-duplicate, and analyze the vast amounts of data that flow into its healthcare Map. This allows the company to connect the dots between individual patient journeys and large-scale health outcomes, providing valuable insights to stakeholders across the healthcare ecosystem, including life sciences companies, payers, providers, and developers. Komodo Health's technology platform and software solutions enable stakeholders to unearth patient-centric insights at scale, informing decision-making, closing gaps in care, addressing disease burden, and helping create a more cost-effective and value-driven healthcare system. The company's offerings span a range of use cases, from finding and recruiting patients for clinical trials to understanding treatment patterns, costs, and outcomes for various therapies.

Komodo Health has made strategic acquisitions and partnerships to enhance its data assets and capabilities further. For instance, it acquired Mavens in 2021, a leader in cloud-based technology solutions for life sciences, allowing Komodo's real-world patient data and analytics software to integrate directly into drug development and research workflows.

Key customers and partnerships

Komodo Health partners with various organizations across the healthcare and life sciences sectors, leveraging its technology platform and data assets to drive innovation and generate insights.

In 2024, Komodo Health announced a multi-year technology partnership with MoonLake Immunotherapeutics, a clinical-stage biotech company focused on inflammatory diseases. MoonLake will utilize Komodo's healthcare Map and platform technologies to enable data-driven decision-making across its clinical operations, medical, marketing, and market access teams, supporting market research, clinical trial site selection, go-to-market strategies, and patient journey mapping.

In April 2024, Komodo health partnered with GeneDx to provide access to GeneDx's rare disease dataset, which includes data from over 500,000 exomes, through the MapEnhance feature of the Healthcare Map platform.

Komodo Health has also collaborated with organizations like Invitae, a leading medical genetics company, to build a clinicogenomic real-world data solution using Komodo's Sentinel application. This allows Invitae to unlock insights into the links between genetics and disease by integrating its de-identified genomic data with Komodo's longitudinal patient journey data.

Additionally, Komodo Health has partnered with companies like Turquoise Health, DeepIntent, and AppliedVR, enabling them to build innovative solutions on Komodo's platform and leverage its healthcare Map's insights for various use cases, such as healthcare pricing, advertising, and clinical studies.